about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesNeuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA DysregulationMay Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewIntegrated miRNA and mRNA Analysis of Time Series Microarray DataRole of microRNA-4516 involved autophagy associated with exposure to fine particulate matterBiases in small RNA deep sequencing data.Transcriptome analysis reveals non-identical microRNA profiles between arterial and venous plasma.Pre-profiling factors influencing serum microRNA levelsStudying the RNA silencing pathway with the p19 protein.MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.Circulating microRNAs serve as novel biological markers for intracranial aneurysms.Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients.Analysis of serum miRNA profiles of myasthenia gravis patients.Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients.Ionizing radiation-induced microRNA expression changes in cultured RGC-5 cells.Exosome-delivered microRNAs modulate the inflammatory response to endotoxin.MicroRNAs as Biomarkers in Cancer.Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure.MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High PhosphorusThe Impact of Hemolysis on Cell-Free microRNA Biomarkers.Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.MicroRNA as therapeutic targets for treatment of depression.Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancerCorrelation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay.Pancreatic cancer diagnosis by free and exosomal miRNA.High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.Circulating microRNAs Correlated with Bone Loss Induced by 45 Days of Bed Rest.Moving RNA moves RNA forward.Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs.Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers.Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes.Implication of microRNA deregulation in the response of vertebrates to endocrine disrupting chemicals.microRNA and Epilepsy.Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach.
P2860
Q26748881-4950A061-EE7F-4B48-AAEE-75A79898993DQ26770754-8DE2EA7E-B2E7-49D8-BF56-5AD7B1D0CB12Q26780339-43506A73-F895-47F3-80B9-80A8A615C542Q26785539-8D968A3D-9B67-474C-8A99-DD8A87AD9554Q28394146-9BA50C28-550D-4BDD-BD27-5ED2EA81D77DQ28583853-BEDCC659-405F-4624-B6E2-8EE38F6C716AQ30689935-90190BD9-389B-462A-BE00-6F0F93124D5AQ33709747-492CA7CF-CB61-4832-9473-F63DCB54024BQ33936328-AA710996-63CF-4624-9D6B-FF79DD16AA6EQ34325833-1C2522C5-2F99-4893-92EF-19E5981CEC62Q34326553-CAB0CED3-EE41-46B5-AC92-0DBDEE10301EQ34645569-5828F02A-A9CE-4512-804C-DCE49F8E41A9Q35070658-97B7FD44-BA79-40A6-A867-494690F52DD2Q35070723-BE7CEF50-E25C-4BCA-9DBE-8A855B12A86AQ35122838-FD16A940-9611-435A-AA8D-80515EC3B035Q35475974-1F9ADEE5-28A9-4D0F-BD9E-93F96F43F17FQ35631955-380E785B-F1BD-4A16-9F2A-EE9132A83DE2Q35665389-7B1E52AA-E629-4074-A8A2-2F032FBFECABQ36018633-8AFD2794-E3BD-40A8-812F-8FC03488ACB6Q36335261-8E73328F-30B2-4F94-AB2E-037E3F013C3EQ36357339-E2CCD199-46AF-4EFA-9070-EF846EFB6EC7Q36624625-E944EB8B-AC1A-4950-A058-E28C51EDAAB4Q36872732-3C20AC70-635A-4049-A8D3-8F654D0A14E4Q36875670-F032B693-E168-4329-94FD-4802ADD75F37Q37014663-C31C2908-729B-45AD-B817-7594FE65B7A4Q37075039-BF96B03F-D9C2-4C93-8D3C-5A25F4C1375AQ37109830-B93DE87F-0DDB-481F-8CD2-46A5D74C4BC1Q37349506-92D3134B-D30B-4D5B-810B-72303CB51667Q37351804-295F4813-2453-457F-90F2-A0F28BEC791BQ37382231-9ABB6F90-157E-4E31-B93B-22EFDE779AA3Q37539656-37DD5854-4908-4F4C-AA09-FFC7886483FBQ37619830-F7DD62F5-E4C2-4E9D-BF2F-6479EBDCBB89Q37639778-3529383D-F510-4B46-93EA-E952F27294A4Q38134570-2ED09BDB-C0CE-4EC0-BF47-1A9AEDCA0FA8Q38136336-1FE0519C-11E6-4568-98F9-E166022E5003Q38244277-74A6E462-B70F-49D7-A174-C6733AC2D7E0Q38296132-41E6E595-D91D-4B37-9E1C-D8AF60860249Q38485758-160B392B-A6FF-41D5-A6D1-9B7B86B20AD5Q38668244-69901B1A-27D1-45A8-B7EA-1CAB2FC30D9EQ38682811-EC7C79B8-71E5-4201-8DDB-FF3F45CE9C2D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cell-free Circulating miRNA Biomarkers in Cancer
@ast
Cell-free Circulating miRNA Biomarkers in Cancer
@en
type
label
Cell-free Circulating miRNA Biomarkers in Cancer
@ast
Cell-free Circulating miRNA Biomarkers in Cancer
@en
prefLabel
Cell-free Circulating miRNA Biomarkers in Cancer
@ast
Cell-free Circulating miRNA Biomarkers in Cancer
@en
P2093
P2860
P356
P1433
P1476
Cell-free Circulating miRNA Biomarkers in Cancer
@en
P2093
Meng-Hsuan Mo
Sidney W Fu
Wendy Wang
P2860
P304
P356
10.7150/JCA.4919
P50
P577
2012-10-13T00:00:00Z